Assessing microbicide acceptability: A comprehensive and integrated approach

AIDS and Behavior

Volumn 12, Issue 2, 2008, Pages 272-283

  Morrow, Kathleen M ^a   Ruiz, Monica S ^b  

^a BROWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acceptability; Clinical trials; Measurement; Microbicides; Preclinical development

Indexed keywords

MICROBICIDE; PLACEBO;

BEHAVIORAL SCIENCE; CLINICAL RESEARCH; CLINICAL TRIAL; CONDOM; DRUG FORMULATION; DRUG RESEARCH; DRUG SAFETY; FOLLOW UP; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; METHODOLOGY; PATIENT SAFETY; PRODUCT DEVELOPMENT; QUALITATIVE RESEARCH; REVIEW; SEXUAL BEHAVIOR; SOCIOLOGY; VISCOSITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; CONSUMER SATISFACTION; CONTRACEPTION BEHAVIOR; DRUG DESIGN; DRUG INTERACTIONS; HEALTH SERVICES RESEARCH; HIV INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUALLY TRANSMITTED DISEASES; SOCIAL SCIENCES;

EID: 43149097841     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-007-9266-z     Document Type: Review

References (32)

1. Barnhart, K. T., Pretorius, E. S., Timbers, K., Shera, D., Shabbout, M., & Malamud, D. (2004). In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception, 70(6), 498-505.
2. Bax, R., Douville, K., McCormick, D., Rosenberg, M., Higgins, J., & Bowden, M. (2002). Microbicides-evaluating multiple formulations of C31G. Contraception, 66(5), 365-368.
3. Bentley, M. E., Morrow, K., Fullem, A., Chesney, M. A., Horton, S. D., Rosenberg, Z., et al. (2000). Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Family Planning Perspectives, 32(4), 184-188.
4. Boonstra, H. (2000). Campaign to accelerate microbicide development for STD prevention gets under way. The Guttmacher Report on Public Policy, 3, 3-4.
5. Coggins, C., Blanchard, K., Alvarez, F., Brache, V., Weisberg, E., Kilmarx, P., et al. (2000). Safety and acceptability of lambda-carageenan- containing vaginal microbicide gel PC-503. Paper presented at the Microbicide 2000, Washington, DC.
6. Denzin, N. K. (1978). The research act: A theoretical introduction to sociological methods (2nd ed.). New York, NY: McGraw Hill.
7. Denzin, N. K., & Lincoln, Y. S. (1998). Introduction. In N. K. Denzin, & Y. S. Lincoln (Eds.), Strategies of qualitative inquiry. Thousand Oaks, CA: Sage Publications.
8. Elias, C., & Coggins, C. (2001). Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? Journal of Women's Health and Gender-Based Medicine, 10(2), 163-173.
9. El-Sadr, W. M., Mayer, K. H., Maslankowski, L., Hoesley, C., Justman, J., Gai, F., Mauck, C., Absalon, J., Carballo-Dieguez, A., Morrow, K., Mâsse., B, Soto-Torres, L. & Kwiecien, A for the HIV Prevention Trials Network (HPTN) 049 Protocol Team. (2006). Safety and Acceptability of Cellulose Sulfate as a Vaginal Microbicide in HIV-infected Women. AIDS, 20(8), 1109-1116.
10. Finley, B. M., Plescia, C. J., Harrison, P. F., & des Vignes, F. N. (2006, Aug 13-18). An analytical overview of the microbicide preclinical and clinical pipeline. Paper presented at the AIDS 2006, Toronto, Canada.
11. Fuchs, E., Wahl, R., Macura, K., Leal, J., Grohskopf, L., & Hendrix, C. (2005). Imaging the distribution and clearance of a rectal microbicide gel and semen surrogate in the lower gastrointestinal tract. Clinical Pharmacology and Therapeutics, 77(2), 60.
12. Geonotti, A. R., & Katz, D. F. (2005). Erosion of microbicide formulation coating layers: Effects of contact and shearing with vaginal fluid or semen. Journal of Pharmaceutical Sciences, 94, 1705-1712.
13. Heise, L. (1997). Beyond acceptability: Reorienting research on contraceptive choice. In WHO (Ed.), Beyond acceptability: Users' perspectives on contraception: Reproductive Health Matters.
14. Kieweg, S. L., Geonnotti, A. R., & Katz, D. F. (2004). Gravity-induced coating flows of vaginal gel formulations: In vitro experimental analysis. Journal of Pharmaceutical Sciences, 93(12), 2941-2952.
15. Kieweg, S. L., & Katz, D. F. (2006). Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. Journal of Biomechanical Engineering, 128(4), 540-553.
16. Mantell, J. E., Myer, L., Carballo-Dieguez, A., Stein, Z., Ramjee, G., Morar, N. S., et al. (2005). Microbicide acceptability research: Current approaches and future directions. Social Science and Medicine, 60(2), 319-330.
17. Mason, T. H., Foster, S. E., Finlinson, H. A., Morrow, K., Rosen, R., Vining, S., et al. (2003). Perspectives related to the potential use of vaginal microbicides among drug-involved women: Focus groups in three cities in the United States and Puerto Rico. AIDS and Behavior, 7(4), 339-351.
18. MDS Working Groups. (2006). The microbicide development strategy. Silver Spring, MD: Alliance for Microbicide Development.
19. Morrow, K. (2006). The use of qualitative methods in formative and evaluative research. Unpublished presentation, Providence, RI.
20. Morrow, K., Costello, T., & Rosen, R. (2003a). Coloring in the lines: Using qualitative data to enhance quantitative findings: The case of microbicide acceptability. Paper presented at the Society of Behavioral Medicine, Salt Lake City, Utah.
21. Morrow, K., Rosen, R., Richter, L., Emans, A., Forbes, A., Day, J., et al. (2003b). The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. Journal of Women's Health, 12(7), 655-666.
22. Murphy, S. T., Miller, L. C., Moore, J., & Clark, L. F. (2000). Preaching to the choir: Preference for female-controlled methods of HIV and sexually transmitted disease prevention. American Journal of Public Health, 90(7), 1135-1137.
23. Ramjee, G., Abdool Karim, S. S., Morar, N., Gwamanda, Z., Xulu, G., Ximba, T., et al. (1999). Acceptability of a vaginal microbicide among female sex workers. South African Medical Journal, 89(6), 673-676.
24. Rosen, R., Morrow, K., Carballo-Dieguez, A., Mantell, J., Hoffman, S., Gai, F., et al. (under review). The acceptability of an antiretroviral vaginal microbicide, Tenofovir Gel, among female participants in a phase I trial (HPTN 050).
25. Severy, L. J., & Newcomer, S. (2005a). Critical issues in contraceptive and STI acceptability research. Journal of Social Issues, 61(1), 45-65.
26. Severy, L. J., Tolley, E., Woodsong, C., & Guest, G. (2005b). A framework for examining the sustained acceptability of microbicides. AIDS and Behavior, 9(1), 121-131.
27. The Rockefeller Foundation. (2002). Mobilization for microbicides: The decisive decade. Retrieved May 16, 2006, from http://www.global-campaign.org/ clientfiles/RockExecSumm.pdf.
28. Tolley, E. E., & Severy, L. J. (2006). Integrating behavioral and social science research into microbicide clinical trials: Challenges and opportunities. American Journal of Public Health, 96(1), 79-83.
29. UNAIDS/WHO. (2005). AIDS epidemic update 2005: Special report on HIV prevention. Geneva, Switzerland.
30. Watts, C., Kumaranayake, L., Vickerman, P., & Terris-Prestholt, F. (2002). New hope for HIV prevention: Projections of the impact of microbicides. Paper presented at the Microbicides 2002, May 12-15, Antwerp, Belgium.
31. WHO. (1997). Beyond acceptability: Users' perspectives on contraception: Reproductive Health Matters for WHO.
32. Wulf, D., Frost, J., & Darroch, J. E. (1999). Microbicides: A new defense against sexually transmitted diseases. New York, NY: The Alan Guttmacher Institute.